AI drug discovery startup Verge Genomics raises $32 million [Video]

Cristian WorthingtonFeedToPost

To see the original post and the Video, click here

Developing new drugs is a challenging enterprise. It costs pharmaceutical companies an average of $2.7 billion to bring medicine to store shelves, according to the Tufts Center for the Study of Drug Development, and as much as 90 percent of treatments in late-stage trials never come to market...

Watch/Read More

Developing new drugs is a challenging enterprise. It costs pharmaceutical companies an average of $2.7 billion to bring medicine to store shelves, according to the Tufts Center for the Study of Drug Development, and as much as 90 percent of treatments in late-stage trials never come to market because they’re deemed ineffective or unsafe.

But Y Combinator graduate Verge Genomics believes that with the help of artificial intelligence, drug …